Literature DB >> 27247183

Global chromatin architecture defines functional cancer hierarchies.

Marco Gallo1, Peter B Dirks2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27247183      PMCID: PMC4993424          DOI: 10.1080/15384101.2016.1191248

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.

Authors:  Jeremy Schwartzentruber; Andrey Korshunov; Xiao-Yang Liu; David T W Jones; Elke Pfaff; Karine Jacob; Dominik Sturm; Adam M Fontebasso; Dong-Anh Khuong Quang; Martje Tönjes; Volker Hovestadt; Steffen Albrecht; Marcel Kool; Andre Nantel; Carolin Konermann; Anders Lindroth; Natalie Jäger; Tobias Rausch; Marina Ryzhova; Jan O Korbel; Thomas Hielscher; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Martin Ebinger; Martin U Schuhmann; Wolfram Scheurlen; Arnulf Pekrun; Michael C Frühwald; Wolfgang Roggendorf; Christoph Kramm; Matthias Dürken; Jeffrey Atkinson; Pierre Lepage; Alexandre Montpetit; Magdalena Zakrzewska; Krzystof Zakrzewski; Pawel P Liberski; Zhifeng Dong; Peter Siegel; Andreas E Kulozik; Marc Zapatka; Abhijit Guha; David Malkin; Jörg Felsberg; Guido Reifenberger; Andreas von Deimling; Koichi Ichimura; V Peter Collins; Hendrik Witt; Till Milde; Olaf Witt; Cindy Zhang; Pedro Castelo-Branco; Peter Lichter; Damien Faury; Uri Tabori; Christoph Plass; Jacek Majewski; Stefan M Pfister; Nada Jabado
Journal:  Nature       Date:  2012-01-29       Impact factor: 49.962

2.  MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.

Authors:  Marco Gallo; Fiona J Coutinho; Robert J Vanner; Tenzin Gayden; Stephen C Mack; Alex Murison; Marc Remke; Ren Li; Naoya Takayama; Kinjal Desai; Lilian Lee; Xiaoyang Lan; Nicole I Park; Dalia Barsyte-Lovejoy; David Smil; Dominik Sturm; Michelle M Kushida; Renee Head; Michael D Cusimano; Mark Bernstein; Ian D Clarke; John E Dick; Stefan M Pfister; Jeremy N Rich; Cheryl H Arrowsmith; Michael D Taylor; Nada Jabado; David P Bazett-Jones; Mathieu Lupien; Peter B Dirks
Journal:  Cancer Cell       Date:  2015-11-25       Impact factor: 31.743

3.  Critical Role of Histone Turnover in Neuronal Transcription and Plasticity.

Authors:  Ian Maze; Wendy Wenderski; Kyung-Min Noh; Rosemary C Bagot; Nikos Tzavaras; Immanuel Purushothaman; Simon J Elsässer; Yin Guo; Carolina Ionete; Yasmin L Hurd; Carol A Tamminga; Tobias Halene; Lorna Farrelly; Alexey A Soshnev; Duancheng Wen; Shahin Rafii; Marc R Birtwistle; Schahram Akbarian; Bruce A Buchholz; Robert D Blitzer; Eric J Nestler; Zuo-Fei Yuan; Benjamin A Garcia; Li Shen; Henrik Molina; C David Allis
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

4.  The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.

Authors:  Stephen H K Wong; David L Goode; Masayuki Iwasaki; Michael C Wei; Hsu-Ping Kuo; Li Zhu; Dominik Schneidawind; Jesus Duque-Afonso; Ziming Weng; Michael L Cleary
Journal:  Cancer Cell       Date:  2015-07-16       Impact factor: 31.743

5.  Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.

Authors:  Peter W Lewis; Manuel M Müller; Matthew S Koletsky; Francisco Cordero; Shu Lin; Laura A Banaszynski; Benjamin A Garcia; Tom W Muir; Oren J Becher; C David Allis
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

6.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Authors:  Dominik Sturm; Hendrik Witt; Volker Hovestadt; Dong-Anh Khuong-Quang; David T W Jones; Carolin Konermann; Elke Pfaff; Martje Tönjes; Martin Sill; Sebastian Bender; Marcel Kool; Marc Zapatka; Natalia Becker; Manuela Zucknick; Thomas Hielscher; Xiao-Yang Liu; Adam M Fontebasso; Marina Ryzhova; Steffen Albrecht; Karine Jacob; Marietta Wolter; Martin Ebinger; Martin U Schuhmann; Timothy van Meter; Michael C Frühwald; Holger Hauch; Arnulf Pekrun; Bernhard Radlwimmer; Tim Niehues; Gregor von Komorowski; Matthias Dürken; Andreas E Kulozik; Jenny Madden; Andrew Donson; Nicholas K Foreman; Rachid Drissi; Maryam Fouladi; Wolfram Scheurlen; Andreas von Deimling; Camelia Monoranu; Wolfgang Roggendorf; Christel Herold-Mende; Andreas Unterberg; Christof M Kramm; Jörg Felsberg; Christian Hartmann; Benedikt Wiestler; Wolfgang Wick; Till Milde; Olaf Witt; Anders M Lindroth; Jeremy Schwartzentruber; Damien Faury; Adam Fleming; Magdalena Zakrzewska; Pawel P Liberski; Krzysztof Zakrzewski; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Sorana Morrissy; Florence Cavalli; Michael D Taylor; Peter van Sluis; Jan Koster; Rogier Versteeg; Richard Volckmann; Tom Mikkelsen; Kenneth Aldape; Guido Reifenberger; V Peter Collins; Jacek Majewski; Andrey Korshunov; Peter Lichter; Christoph Plass; Nada Jabado; Stefan M Pfister
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

7.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

Authors:  Sam Behjati; Patrick S Tarpey; Nadège Presneau; Susanne Scheipl; Nischalan Pillay; Peter Van Loo; David C Wedge; Susanna L Cooke; Gunes Gundem; Helen Davies; Serena Nik-Zainal; Sancha Martin; Stuart McLaren; Victoria Goodie; Ben Robinson; Adam Butler; Jon W Teague; Dina Halai; Bhavisha Khatri; Ola Myklebost; Daniel Baumhoer; Gernot Jundt; Rifat Hamoudi; Roberto Tirabosco; M Fernanda Amary; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Adrienne M Flanagan
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.